THOMPSON SIEGEL & WALMSLEY LLC - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 271 filers reported holding HAEMONETICS CORP in Q3 2022. The put-call ratio across all filers is 1.37 and the average weighting 0.1%.

Quarter-by-quarter ownership
THOMPSON SIEGEL & WALMSLEY LLC ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q4 2022$2
-100.0%
22
-100.0%
0.00%
-100.0%
Q3 2022$12,829,000
-19.0%
173,290
-28.7%
0.22%
-12.9%
Q2 2022$15,840,000
-10.2%
243,013
-12.9%
0.26%
+1.6%
Q1 2022$17,647,000
+15.2%
279,142
-3.4%
0.25%
+19.0%
Q4 2021$15,322,000
-10.2%
288,873
+19.5%
0.21%
-14.2%
Q3 2021$17,066,000
-20.1%
241,763
-24.5%
0.25%
-15.8%
Q2 2021$21,352,000
+1067500.0%
320,413
+533921.7%
0.29%
Q4 2016$2,000600.00%
Other shareholders
HAEMONETICS CORP shareholders Q3 2022
NameSharesValueWeighting ↓
LGT CAPITAL PARTNERS LTD. 1,216,059$64,500,0001.72%
HEARTLAND ADVISORS INC 406,192$21,544,0001.26%
KINGDON CAPITAL MANAGEMENT, L.L.C. 200,000$10,608,0001.22%
Aurora Investment Counsel 32,149$1,705,0001.01%
Endurant Capital Management LP 73,914$3,920,0000.95%
KINGDON CAPITAL MANAGEMENT, L.L.C. 135,000$7,160,0000.82%
ARMISTICE CAPITAL, LLC 872,000$46,251,0000.76%
Summit Creek Advisors LLC 131,357$6,967,0000.70%
Dean Capital Management 15,309$812,0000.70%
Keene & Associates, Inc. 11,720$622,0000.54%
View complete list of HAEMONETICS CORP shareholders